Rubiwin-L Tablet SR
Marketer
Vhl Pharmaceuticals Private Limited
Salt Composition
Levosulpiride (75mg) + Esomeprazole (20mg)
Overview Rubiwin-L Tablet SR
Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with the prescription medication, L-Rubiwin SR tablets. This medication targets symptoms like heartburn, abdominal pain, and irritation by reducing stomach acid production. L-Rubiwin SR tablets should be taken on an empty stomach, following your doctor's prescribed dosage and duration. Your individual dosage will be determined by your condition and response to treatment. Consistent use, as directed by your physician, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all other medications you're using, as interactions are possible. Common side effects—diarrhea, nausea, vomiting, abdominal pain, gas, constipation, and headache—are usually temporary. Report any concerning side effects immediately to your doctor. Constipation can often be mitigated by increasing dietary fiber and fluid intake. Drowsiness is a potential side effect; avoid driving or activities requiring alertness until its impact is known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, may enhance treatment efficacy. If pregnant, planning pregnancy, breastfeeding, or have liver or kidney conditions, inform your doctor before starting this medication to ensure appropriate dosage.
Primary Ingredients of Rubiwin-L Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Rubiwin-L Tablet SR
Managing Gastroesophageal Reflux Disease (GERD)
Major Benefits of Rubiwin-L Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the Rubiwin-L Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Rubiwin-L Tablet SR:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Upset stomach
- Stomach pain
- Headache
- Flatulence
- Sleepiness
- Fundic gland polyps
How to use Rubiwin-L Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Rubiwin-L Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
How Rubiwin-L Tablet SR works:
Levosulpiride and esomeprazole are combined in the extended-release Rubiwin-L Tablet.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Rubiwin-L Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Rubiwin-L SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Rubiwin-L Tablet SR use while breastfeeding is absent. Seek your physician's advice.
DrivingUNSAFE
Driving ability may be impaired by Rubiwin-L Tablet SR, which can induce drowsiness, numbness, or dyskinesia. Consequently, patients should refrain from driving or operating machinery demanding close attention.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Rubiwin-L Tablet SR administration to individuals with renal impairment. Physician consultation is advised. Preliminary findings, however, indicate that its use in such patients should be approached with prudence.
LiverCAUTION
Patients with severe hepatic impairment should use Rubiwin-L Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Rubiwin-L Tablet SR :
Should you forget a Rubiwin-L Tablet SR dose, take it immediately if possible. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rubiwin-L Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |



